Antibacterial modified chitosan-based hemostatic material and method of manufacturing the same
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
Mar 4, 2025
Grant Date -
N/A
app pub date -
Oct 7, 2024
filing date -
Oct 7, 2024
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A method of manufacturing the antibacterial modified chitosan-based hemostatic material comprising: (i) preparing materials including: a modified chitosan ingredient and third different solutions including a solution containing polysaccharide, a solution containing dissolving solvent, and a solution containing nano silver; (ii) mixing the solutions prepared in step (i) to create a foundation mixture; (iii) loading the foundation mixture into a electrospinning device according to predetermined specifications to obtain the antibacterial modified chitosan-based hemostatic material in the form of nanofibers; and (iv) applying the antibacterial modified chitosan-based hemostatic material to a bleeding tissue on the surface of skin of a subject in need thereof to prevent bleeding and fluid exudation from the tissue, and promoting bacteriostatic and anti-inflammatory effects on the wound surface.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully